Zyglob 10% Human Normal Immunoglobulin Injection

Product Description

Zyglob Injection 100 ml belongs to the class of medications called 'immunising agents used to treat immunoglobulin (antibody) deficiency and certain inflammatory disorders. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). Zyglob Injection 100 ml is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).

Zyglob Injection 100 ml contains 'Human normal immunoglobulin, which replaces the deficient antibodies necessary to act against infections and inflammation. It works exactly as the immunoglobulins present in the body. Immunoglobulins are an essential part of the immune system, which recognises the antigens or foreign elements in the body and aids in their destruction. It also helps to reduce inflammation by improving immunity.

Function and Indications

Zyglob 10% acts as an immunoglobulin replacement therapy, essential for patients with compromised immune systems. It is recommended for primary and secondary immunodeficiencies, idiopathic thrombocytopenic purpura, Kawasaki syndrome, and other medical situations requiring passive immunity. Its wide clinical application renders it a vital supportive treatment.


Administration and Safety

Administered intravenously, Zyglob 10% requires skilled healthcare supervision. The infusion rate should be adjusted based on patient tolerance, with careful monitoring for any allergic reactions during administration. Usage is contraindicated in patients with known hypersensitivity to immunoglobulins or certain excipients, and in those with selective IgA deficiency who possess anti-IgA antibodies.


Storage and Quality Standards

Zyglob 10% must be stored below 25C, shielded from light and never frozen, to preserve its stability and efficacy. Developed in a WHO-GMP certified facility, the product meets international export standards. Each batch maintains strict quality assurance from manufacture through distribution.